English

MEDIMMUNE INC /DE

EDGAR

Annual report amendment (10-K/A) · filed 2007-04-30

59 filing records in this dataset, filed from 1996-08-14 to 2007-04-30. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

575 million USD

2007-03-31 · USD

Exact inputs and evidence

Revenue: 574800000 USD Source

Operating margin

40.43%

2007-03-31 · %

Exact inputs and evidence

Operating Income: 232400000 USD Source
Revenue: 574800000 USD Source

Operating cash flow

185 million USD

2007-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: 184900000 USD Source

Free cash flow

153 million USD

2007-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: 184900000 USD Source
Capital Expenditure: 31600000 USD Source

Cash and cash equivalents: 463 million USD 2007-03-31 Source
Exact value

463300000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

1.35 billion USD

2006-04-01 – 2007-03-31

Exact inputs and evidence

Revenue: 72900000 USD · 2006-04-01 – 2006-06-30 Source
Revenue: 177200000 USD · 2006-07-01 – 2006-09-30 Source
Revenue: 1276800000 USD · 2006-01-01 – 2006-12-31 Source
Revenue: 748100000 USD · 2006-01-01 – 2006-09-30 Source
Revenue: 574800000 USD · 2007-01-01 – 2007-03-31 Source

Net income

162 million USD

2006-04-01 – 2007-03-31

Exact inputs and evidence

Net income: -63200000 USD · 2006-04-01 – 2006-06-30 Source
Net income: -55800000 USD · 2006-07-01 – 2006-09-30 Source
Net income: 48700000 USD · 2006-01-01 – 2006-12-31 Source
Net income: -72000000 USD · 2006-01-01 – 2006-09-30 Source
Net income: 160000000 USD · 2007-01-01 – 2007-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2007-04-30.

Financial data available through: 2006-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2006-12-31
Operating income: 11 of 11 periods available· newest 2006-12-31
Net income: 11 of 11 periods available· newest 2006-12-31
Operating cash flow: 11 of 11 periods available· newest 2006-12-31
Capital expenditure: 11 of 11 periods available· newest 2006-12-31
Total assets: 11 of 11 periods available· newest 2006-12-31
Total liabilities: 11 of 11 periods available· newest 2006-12-31
Current assets: 11 of 11 periods available· newest 2006-12-31
Current liabilities: 11 of 11 periods available· newest 2006-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2006-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+2.6%

Prior period

USD 1.24 billion

2005-01-01 – 2005-12-31
Current period

USD 1.28 billion

2006-01-01 – 2006-12-31

Exact inputs and evidence

1276800000 − 1243900000 = 32900000 USD

1243900000 USD · 2005-01-01 – 2005-12-31
Inspect prior input Prior source
1276800000 USD · 2006-01-01 – 2006-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · MEDIMMUNE INC /DE · 2006-12-31 MEDIMMUNE INC /DE (edgar:873591) Year-over-year change in Revenue: 32900000 USD Concept: fundies:Revenue Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/873591?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 1276800000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0001104659-07-014449.txt#11089 Input fundies:Revenue: 1243900000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0001104659-07-014449.txt#11089
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 65.3 million

Prior period

−USD 16.6 million

2005-01-01 – 2005-12-31
Current period

USD 48.7 million

2006-01-01 – 2006-12-31

Exact inputs and evidence

48700000 − -16600000 = 65300000 USD

-16600000 USD · 2005-01-01 – 2005-12-31
Inspect prior input Prior source
48700000 USD · 2006-01-01 – 2006-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · MEDIMMUNE INC /DE · 2006-12-31 MEDIMMUNE INC /DE (edgar:873591) Year-over-year change in Net income: 65300000 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/873591?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 48700000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0001104659-07-014449.txt#11769 Input fundies:NetIncome: -16600000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0001104659-07-014449.txt#11769
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-215.3%

Prior period

USD 110.7 million

2005-01-01 – 2005-12-31
Current period

−USD 127.6 million

2006-01-01 – 2006-12-31

Exact inputs and evidence

-127600000 − 110700000 = -238300000 USD

110700000 USD · 2005-01-01 – 2005-12-31
Inspect prior input Prior source
-127600000 USD · 2006-01-01 – 2006-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · MEDIMMUNE INC /DE · 2006-12-31 MEDIMMUNE INC /DE (edgar:873591) Year-over-year change in Operating cash flow: -238300000 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/873591?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -127600000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0001104659-07-014449.txt#12393 Input fundies:OperatingCashFlow: 110700000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0001104659-07-014449.txt#12393
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+55.4%

Prior period

USD 91.5 million

2005-01-01 – 2005-12-31
Current period

USD 142.2 million

2006-01-01 – 2006-12-31

Exact inputs and evidence

142200000 − 91500000 = 50700000 USD

91500000 USD · 2005-01-01 – 2005-12-31
Inspect prior input Prior source
142200000 USD · 2006-01-01 – 2006-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · MEDIMMUNE INC /DE · 2006-12-31 MEDIMMUNE INC /DE (edgar:873591) Year-over-year change in Capital expenditure: 50700000 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/873591?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 142200000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0001104659-07-014449.txt#12527 Input fundies:CapitalExpenditure: 91500000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0001104659-07-014449.txt#12527
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2006 2006-01-01 – 2006-12-31

Revenue USD 1.28 billion 100% of revenue
Operating costs Derived USD 1.29 billion 101% of revenue
Operating income −USD 8.5 million −0.7% of revenue
Tax, interest and other Derived −USD 57.2 million −4.5% of revenue
Net income USD 48.7 million 3.8% of revenue

Cash

Operating cash flow −USD 127.6 million −10% of revenue
Capital expenditure USD 142.2 million 11% of revenue
Free cash flow Derived −USD 269.8 million −21% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1997 Operating loss: operating costs were 145% of revenue.
1998 Operating loss: operating costs were 102% of revenue.
1999 Net income was higher than operating income, so the split is not drawn.
2000 27%67%
2001 24%69%
2002 Operating loss: operating costs were 226% of revenue.
2003 17%77%
2004 Operating loss: operating costs were 106% of revenue.
2005 Operating loss: operating costs were 103% of revenue.
2006 Operating loss: operating costs were 101% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1997 1997-01-01 – 1997-12-31	105748000	153713000 Derived	-47965000	-3161000 Derived	-44804000	-92057000 Derived	Source 1997-01-01 – 1997-12-31: 105748000 USD Inspect Revenue Open source 1997-01-01 – 1997-12-31: -47965000 USD Inspect Operating Income Open source 1997-01-01 – 1997-12-31: -44804000 USD Inspect Net Income Open source 1997-01-01 – 1997-12-31: -54453000 USD Inspect Operating Cash Flow Open source 1997-01-01 – 1997-12-31: 37604000 USD Inspect Capital Expenditure Open source
1998 1998-01-01 – 1998-12-31	227221000	232668000 Derived	-5447000	-52634000 Derived	47187000	-5853000 Derived	Source 1998-01-01 – 1998-12-31: 227221000 USD Inspect Revenue Open source 1998-01-01 – 1998-12-31: -5447000 USD Inspect Operating Income Open source 1998-01-01 – 1998-12-31: 47187000 USD Inspect Net Income Open source 1998-01-01 – 1998-12-31: 5113000 USD Inspect Operating Cash Flow Open source 1998-01-01 – 1998-12-31: 10966000 USD Inspect Capital Expenditure Open source
1999 1999-01-01 – 1999-12-31	383375000	306556000 Derived	76819000	-16552000 Derived	93371000	46650000 Derived	Source 1999-01-01 – 1999-12-31: 383375000 USD Inspect Revenue Open source 1999-01-01 – 1999-12-31: 76819000 USD Inspect Operating Income Open source 1999-01-01 – 1999-12-31: 93371000 USD Inspect Net Income Open source 1999-01-01 – 1999-12-31: 58853000 USD Inspect Operating Cash Flow Open source 1999-01-01 – 1999-12-31: 12203000 USD Inspect Capital Expenditure Open source
2000 2000-01-01 – 2000-12-31	540495000	360177000 Derived	180318000	35341000 Derived	144977000	164675000 Derived	Source 2000-01-01 – 2000-12-31: 540495000 USD Inspect Revenue Open source 2000-01-01 – 2000-12-31: 180318000 USD Inspect Operating Income Open source 2000-01-01 – 2000-12-31: 144977000 USD Inspect Net Income Open source 2000-01-01 – 2000-12-31: 173263000 USD Inspect Operating Cash Flow Open source 2000-01-01 – 2000-12-31: 8588000 USD Inspect Capital Expenditure Open source
2001 2001-01-01 – 2001-12-31	620664000	428124000 Derived	192540000	43580000 Derived	148960000	232657000 Derived	Source 2001-01-01 – 2001-12-31: 620664000 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: 192540000 USD Inspect Operating Income Open source 2001-01-01 – 2001-12-31: 148960000 USD Inspect Net Income Open source 2001-01-01 – 2001-12-31: 250915000 USD Inspect Operating Cash Flow Open source 2001-01-01 – 2001-12-31: 18258000 USD Inspect Capital Expenditure Open source
2002 2002-01-01 – 2002-12-31	852700000	1928700000 Derived	-1076000000	22000000 Derived	-1098000000	182600000 Derived	Source 2002-01-01 – 2002-12-31: 852700000 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: -1076000000 USD Inspect Operating Income Open source 2002-01-01 – 2002-12-31: -1098000000 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: 263500000 USD Inspect Operating Cash Flow Open source 2002-01-01 – 2002-12-31: 80900000 USD Inspect Capital Expenditure Open source
2003 2003-01-01 – 2003-12-31	1054400000	813100000 Derived	241300000	58100000 Derived	183200000	244600000 Derived	Source 2003-01-01 – 2003-12-31: 1054400000 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: 241300000 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: 183200000 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: 357500000 USD Inspect Operating Cash Flow Open source 2003-01-01 – 2003-12-31: 112900000 USD Inspect Capital Expenditure Open source
2004 2004-01-01 – 2004-12-31	1141100000	1204700000 Derived	-63600000	-59800000 Derived	-3800000	64900000 Derived	Source 2004-01-01 – 2004-12-31: 1141100000 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -63600000 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -3800000 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: 144700000 USD Inspect Operating Cash Flow Open source 2004-01-01 – 2004-12-31: 79800000 USD Inspect Capital Expenditure Open source
2005 2005-01-01 – 2005-12-31	1243900000	1280600000 Derived	-36700000	-20100000 Derived	-16600000	19200000 Derived	Source 2005-01-01 – 2005-12-31: 1243900000 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: -36700000 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: -16600000 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: 110700000 USD Inspect Operating Cash Flow Open source 2005-01-01 – 2005-12-31: 91500000 USD Inspect Capital Expenditure Open source
2006 2006-01-01 – 2006-12-31	1276800000	1285300000 Derived	-8500000	-57200000 Derived	48700000	-269800000 Derived	Source 2006-01-01 – 2006-12-31: 1276800000 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: -8500000 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: 48700000 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: -127600000 USD Inspect Operating Cash Flow Open source 2006-01-01 – 2006-12-31: 142200000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 1.3B 2006

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19971997-12-31	Revenue	105748000	Revenue: 105748000 Open source
19981998-12-31	Revenue	227221000	Revenue: 227221000 Open source
19991999-12-31	Revenue	383375000	Revenue: 383375000 Open source
20002000-12-31	Revenue	540495000	Revenue: 540495000 Open source
20012001-12-31	Revenue	620664000	Revenue: 620664000 Open source
20022002-12-31	Revenue	852700000	Revenue: 852700000 Open source
20032003-12-31	Revenue	1054400000	Revenue: 1054400000 Open source
20042004-12-31	Revenue	1141100000	Revenue: 1141100000 Open source
20052005-12-31	Revenue	1243900000	Revenue: 1243900000 Open source
20062006-12-31	Revenue	1276800000	Revenue: 1276800000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

2.6% 2006

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19971997-12-31	Year over year	157.3%	Revenue: 105748000 Open source Revenue: 41099000 Open source
19981998-12-31	Year over year	114.9%	Revenue: 227221000 Open source Revenue: 105748000 Open source
19991999-12-31	Year over year	68.7%	Revenue: 383375000 Open source Revenue: 227221000 Open source
20002000-12-31	Year over year	41%	Revenue: 540495000 Open source Revenue: 383375000 Open source
20012001-12-31	Year over year	14.8%	Revenue: 620664000 Open source Revenue: 540495000 Open source
20022002-12-31	Year over year	37.4%	Revenue: 852700000 Open source Revenue: 620664000 Open source
20032003-12-31	Year over year	23.7%	Revenue: 1054400000 Open source Revenue: 852700000 Open source
20042004-12-31	Year over year	8.2%	Revenue: 1141100000 Open source Revenue: 1054400000 Open source
20052005-12-31	Year over year	9%	Revenue: 1243900000 Open source Revenue: 1141100000 Open source
20062006-12-31	Year over year	2.6%	Revenue: 1276800000 Open source Revenue: 1243900000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -0.7% 2006

Net margin 3.8% 2006

Free cash flow margin -21.1% 2006

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19971997-12-31	Operating margin	-45.4%	Operating Income: -47965000 Open source Revenue: 105748000 Open source
19981998-12-31	Operating margin	-2.4%	Operating Income: -5447000 Open source Revenue: 227221000 Open source
19991999-12-31	Operating margin	20%	Operating Income: 76819000 Open source Revenue: 383375000 Open source
20002000-12-31	Operating margin	33.4%	Operating Income: 180318000 Open source Revenue: 540495000 Open source
20012001-12-31	Operating margin	31%	Operating Income: 192540000 Open source Revenue: 620664000 Open source
20022002-12-31	Operating margin	-126.2%	Operating Income: -1076000000 Open source Revenue: 852700000 Open source
20032003-12-31	Operating margin	22.9%	Operating Income: 241300000 Open source Revenue: 1054400000 Open source
20042004-12-31	Operating margin	-5.6%	Operating Income: -63600000 Open source Revenue: 1141100000 Open source
20052005-12-31	Operating margin	-3%	Operating Income: -36700000 Open source Revenue: 1243900000 Open source
20062006-12-31	Operating margin	-0.7%	Operating Income: -8500000 Open source Revenue: 1276800000 Open source
19971997-12-31	Net margin	-42.4%	Net Income: -44804000 Open source Revenue: 105748000 Open source
19981998-12-31	Net margin	20.8%	Net Income: 47187000 Open source Revenue: 227221000 Open source
19991999-12-31	Net margin	24.4%	Net Income: 93371000 Open source Revenue: 383375000 Open source
20002000-12-31	Net margin	26.8%	Net Income: 144977000 Open source Revenue: 540495000 Open source
20012001-12-31	Net margin	24%	Net Income: 148960000 Open source Revenue: 620664000 Open source
20022002-12-31	Net margin	-128.8%	Net Income: -1098000000 Open source Revenue: 852700000 Open source
20032003-12-31	Net margin	17.4%	Net Income: 183200000 Open source Revenue: 1054400000 Open source
20042004-12-31	Net margin	-0.3%	Net Income: -3800000 Open source Revenue: 1141100000 Open source
20052005-12-31	Net margin	-1.3%	Net Income: -16600000 Open source Revenue: 1243900000 Open source
20062006-12-31	Net margin	3.8%	Net Income: 48700000 Open source Revenue: 1276800000 Open source
19971997-12-31	Free cash flow margin	-87.1%	Revenue: 105748000 Open source Operating Cash Flow: -54453000 Open source Capital Expenditure: 37604000 Open source
19981998-12-31	Free cash flow margin	-2.6%	Revenue: 227221000 Open source Operating Cash Flow: 5113000 Open source Capital Expenditure: 10966000 Open source
19991999-12-31	Free cash flow margin	12.2%	Revenue: 383375000 Open source Operating Cash Flow: 58853000 Open source Capital Expenditure: 12203000 Open source
20002000-12-31	Free cash flow margin	30.5%	Revenue: 540495000 Open source Operating Cash Flow: 173263000 Open source Capital Expenditure: 8588000 Open source
20012001-12-31	Free cash flow margin	37.5%	Revenue: 620664000 Open source Operating Cash Flow: 250915000 Open source Capital Expenditure: 18258000 Open source
20022002-12-31	Free cash flow margin	21.4%	Revenue: 852700000 Open source Operating Cash Flow: 263500000 Open source Capital Expenditure: 80900000 Open source
20032003-12-31	Free cash flow margin	23.2%	Revenue: 1054400000 Open source Operating Cash Flow: 357500000 Open source Capital Expenditure: 112900000 Open source
20042004-12-31	Free cash flow margin	5.7%	Revenue: 1141100000 Open source Operating Cash Flow: 144700000 Open source Capital Expenditure: 79800000 Open source
20052005-12-31	Free cash flow margin	1.5%	Revenue: 1243900000 Open source Operating Cash Flow: 110700000 Open source Capital Expenditure: 91500000 Open source
20062006-12-31	Free cash flow margin	-21.1%	Revenue: 1276800000 Open source Operating Cash Flow: -127600000 Open source Capital Expenditure: 142200000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -127.6M 2006

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19971997-12-31	Operating cash flow	-54453000	Operating Cash Flow: -54453000 Open source
19981998-12-31	Operating cash flow	5113000	Operating Cash Flow: 5113000 Open source
19991999-12-31	Operating cash flow	58853000	Operating Cash Flow: 58853000 Open source
20002000-12-31	Operating cash flow	173263000	Operating Cash Flow: 173263000 Open source
20012001-12-31	Operating cash flow	250915000	Operating Cash Flow: 250915000 Open source
20022002-12-31	Operating cash flow	263500000	Operating Cash Flow: 263500000 Open source
20032003-12-31	Operating cash flow	357500000	Operating Cash Flow: 357500000 Open source
20042004-12-31	Operating cash flow	144700000	Operating Cash Flow: 144700000 Open source
20052005-12-31	Operating cash flow	110700000	Operating Cash Flow: 110700000 Open source
20062006-12-31	Operating cash flow	-127600000	Operating Cash Flow: -127600000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -269.8M 2006

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19971997-12-31	Free cash flow	-92057000	Operating Cash Flow: -54453000 Open source Capital Expenditure: 37604000 Open source
19981998-12-31	Free cash flow	-5853000	Operating Cash Flow: 5113000 Open source Capital Expenditure: 10966000 Open source
19991999-12-31	Free cash flow	46650000	Operating Cash Flow: 58853000 Open source Capital Expenditure: 12203000 Open source
20002000-12-31	Free cash flow	164675000	Operating Cash Flow: 173263000 Open source Capital Expenditure: 8588000 Open source
20012001-12-31	Free cash flow	232657000	Operating Cash Flow: 250915000 Open source Capital Expenditure: 18258000 Open source
20022002-12-31	Free cash flow	182600000	Operating Cash Flow: 263500000 Open source Capital Expenditure: 80900000 Open source
20032003-12-31	Free cash flow	244600000	Operating Cash Flow: 357500000 Open source Capital Expenditure: 112900000 Open source
20042004-12-31	Free cash flow	64900000	Operating Cash Flow: 144700000 Open source Capital Expenditure: 79800000 Open source
20052005-12-31	Free cash flow	19200000	Operating Cash Flow: 110700000 Open source Capital Expenditure: 91500000 Open source
20062006-12-31	Free cash flow	-269800000	Operating Cash Flow: -127600000 Open source Capital Expenditure: 142200000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

53.4% 2006

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
19971997-12-31	Liabilities / assets	100%	Total Liabilities: 170336000 Open source Total Assets: 170336000 Open source
19981998-12-31	Liabilities / assets	38.7%	Total Liabilities: 157211000 Open source Total Assets: 405777000 Open source
19991999-12-31	Liabilities / assets	17.2%	Total Liabilities: 111345000 Open source Total Assets: 648424000 Open source
20002000-12-31	Liabilities / assets	16.2%	Total Liabilities: 162993000 Open source Total Assets: 1006575000 Open source
20012001-12-31	Liabilities / assets	15.6%	Total Liabilities: 192582000 Open source Total Assets: 1236855000 Open source
20022002-12-31	Liabilities / assets	23.4%	Total Liabilities: 511055000 Open source Total Assets: 2188289000 Open source
20032003-12-31	Liabilities / assets	39.2%	Total Liabilities: 1095400000 Open source Total Assets: 2794600000 Open source
20042004-12-31	Liabilities / assets	34.7%	Total Liabilities: 889800000 Open source Total Assets: 2564400000 Open source
20052005-12-31	Liabilities / assets	43.5%	Total Liabilities: 1209500000 Open source Total Assets: 2780000000 Open source
20062006-12-31	Liabilities / assets	53.4%	Total Liabilities: 1576000000 Open source Total Assets: 2953200000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.93× 2006

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
19971997-12-31	Current assets / current liabilities	2.3×	Current Assets: 100223000 Open source Current Liabilities: 43660000 Open source
19981998-12-31	Current assets / current liabilities	3.69×	Current Assets: 256045000 Open source Current Liabilities: 69450000 Open source
19991999-12-31	Current assets / current liabilities	4.06×	Current Assets: 401838000 Open source Current Liabilities: 98952000 Open source
20002000-12-31	Current assets / current liabilities	4.54×	Current Assets: 687812000 Open source Current Liabilities: 151465000 Open source
20012001-12-31	Current assets / current liabilities	3.01×	Current Assets: 547180000 Open source Current Liabilities: 182015000 Open source
20022002-12-31	Current assets / current liabilities	2.79×	Current Assets: 743433000 Open source Current Liabilities: 266653000 Open source
20032003-12-31	Current assets / current liabilities	2.82×	Current Assets: 1102700000 Open source Current Liabilities: 390700000 Open source
20042004-12-31	Current assets / current liabilities	1.91×	Current Assets: 693800000 Open source Current Liabilities: 363800000 Open source
20052005-12-31	Current assets / current liabilities	0.9×	Current Assets: 1037300000 Open source Current Liabilities: 1148500000 Open source
20062006-12-31	Current assets / current liabilities	2.93×	Current Assets: 1205500000 Open source Current Liabilities: 411200000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1997 1997-01-01 – 1997-12-31	−USD 44.8 million Exact value Exact value: -44804000 USD 1997-01-01 – 1997-12-31: -44804000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MEDIMMUNE INC /DE · 1997-12-31 MEDIMMUNE INC /DE (edgar:873591) Net Income: -44804000 USD Concept: fundies:NetIncome Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/873591/explain?concept=fundies%3ANetIncome&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:NetIncome: -44804000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0000912057-00-011304.txt#3049 The citation records this snapshot. The page link may show a newer release later.	−USD 54.45 million Exact value Exact value: -54453000 USD 1997-01-01 – 1997-12-31: -54453000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MEDIMMUNE INC /DE · 1997-12-31 MEDIMMUNE INC /DE (edgar:873591) Operating Cash Flow: -54453000 USD Concept: fundies:OperatingCashFlow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/873591/explain?concept=fundies%3AOperatingCashFlow&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -54453000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0000912057-00-011304.txt#3072 The citation records this snapshot. The page link may show a newer release later.	USD 37.6 million Exact value Exact value: 37604000 USD 1997-01-01 – 1997-12-31: 37604000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MEDIMMUNE INC /DE · 1997-12-31 MEDIMMUNE INC /DE (edgar:873591) Capital Expenditure: 37604000 USD Concept: fundies:CapitalExpenditure Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/873591/explain?concept=fundies%3ACapitalExpenditure&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 37604000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0000912057-00-011304.txt#3078 The citation records this snapshot. The page link may show a newer release later.	−USD 92.06 million Calculation and evidence -54453000 − 37604000 USD Exact free cash flow: -92057000 USD 1997-01-01 – 1997-12-31: -54453000 USD · Inspect Operating Cash Flow · Source 1997-01-01 – 1997-12-31: 37604000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MEDIMMUNE INC /DE · 1997-12-31 MEDIMMUNE INC /DE (edgar:873591) Free cash flow: -92057000 USD Concept: free-cash-flow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/873591?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -54453000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0000912057-00-011304.txt#3072 Input fundies:CapitalExpenditure: 37604000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0000912057-00-011304.txt#3078 The citation records this snapshot. The page link may show a newer release later.
1998 1998-01-01 – 1998-12-31	USD 47.19 million Exact value Exact value: 47187000 USD 1998-01-01 – 1998-12-31: 47187000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MEDIMMUNE INC /DE · 1998-12-31 MEDIMMUNE INC /DE (edgar:873591) Net Income: 47187000 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/873591/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: 47187000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0000873591-01-000008.txt#2147 The citation records this snapshot. The page link may show a newer release later.	USD 5.11 million Exact value Exact value: 5113000 USD 1998-01-01 – 1998-12-31: 5113000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MEDIMMUNE INC /DE · 1998-12-31 MEDIMMUNE INC /DE (edgar:873591) Operating Cash Flow: 5113000 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/873591/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 5113000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0000873591-01-000008.txt#2175 The citation records this snapshot. The page link may show a newer release later.	USD 10.97 million Exact value Exact value: 10966000 USD 1998-01-01 – 1998-12-31: 10966000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MEDIMMUNE INC /DE · 1998-12-31 MEDIMMUNE INC /DE (edgar:873591) Capital Expenditure: 10966000 USD Concept: fundies:CapitalExpenditure Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/873591/explain?concept=fundies%3ACapitalExpenditure&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 10966000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0000873591-01-000008.txt#2181 The citation records this snapshot. The page link may show a newer release later.	−USD 5.85 million Calculation and evidence 5113000 − 10966000 USD Exact free cash flow: -5853000 USD 1998-01-01 – 1998-12-31: 5113000 USD · Inspect Operating Cash Flow · Source 1998-01-01 – 1998-12-31: 10966000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MEDIMMUNE INC /DE · 1998-12-31 MEDIMMUNE INC /DE (edgar:873591) Free cash flow: -5853000 USD Concept: free-cash-flow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/873591?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 5113000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0000873591-01-000008.txt#2175 Input fundies:CapitalExpenditure: 10966000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0000873591-01-000008.txt#2181 The citation records this snapshot. The page link may show a newer release later.
1999 1999-01-01 – 1999-12-31	USD 93.37 million Exact value Exact value: 93371000 USD 1999-01-01 – 1999-12-31: 93371000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MEDIMMUNE INC /DE · 1999-12-31 MEDIMMUNE INC /DE (edgar:873591) Net Income: 93371000 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/873591/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: 93371000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0000873591-02-000019.txt#2834 The citation records this snapshot. The page link may show a newer release later.	USD 58.85 million Exact value Exact value: 58853000 USD 1999-01-01 – 1999-12-31: 58853000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MEDIMMUNE INC /DE · 1999-12-31 MEDIMMUNE INC /DE (edgar:873591) Operating Cash Flow: 58853000 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/873591/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 58853000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0000873591-02-000019.txt#2859 The citation records this snapshot. The page link may show a newer release later.	USD 12.2 million Exact value Exact value: 12203000 USD 1999-01-01 – 1999-12-31: 12203000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MEDIMMUNE INC /DE · 1999-12-31 MEDIMMUNE INC /DE (edgar:873591) Capital Expenditure: 12203000 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/873591/explain?concept=fundies%3ACapitalExpenditure&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 12203000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0000873591-02-000019.txt#2866 The citation records this snapshot. The page link may show a newer release later.	USD 46.65 million Calculation and evidence 58853000 − 12203000 USD Exact free cash flow: 46650000 USD 1999-01-01 – 1999-12-31: 58853000 USD · Inspect Operating Cash Flow · Source 1999-01-01 – 1999-12-31: 12203000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MEDIMMUNE INC /DE · 1999-12-31 MEDIMMUNE INC /DE (edgar:873591) Free cash flow: 46650000 USD Concept: free-cash-flow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/873591?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 58853000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0000873591-02-000019.txt#2859 Input fundies:CapitalExpenditure: 12203000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0000873591-02-000019.txt#2866 The citation records this snapshot. The page link may show a newer release later.
2000 2000-01-01 – 2000-12-31	USD 144.98 million Exact value Exact value: 144977000 USD 2000-01-01 – 2000-12-31: 144977000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MEDIMMUNE INC /DE · 2000-12-31 MEDIMMUNE INC /DE (edgar:873591) Net Income: 144977000 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/873591/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: 144977000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0001047469-03-007637.txt#5307 The citation records this snapshot. The page link may show a newer release later.	USD 173.26 million Exact value Exact value: 173263000 USD 2000-01-01 – 2000-12-31: 173263000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MEDIMMUNE INC /DE · 2000-12-31 MEDIMMUNE INC /DE (edgar:873591) Operating Cash Flow: 173263000 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/873591/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 173263000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0001047469-03-007637.txt#5819 The citation records this snapshot. The page link may show a newer release later.	USD 8.59 million Exact value Exact value: 8588000 USD 2000-01-01 – 2000-12-31: 8588000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MEDIMMUNE INC /DE · 2000-12-31 MEDIMMUNE INC /DE (edgar:873591) Capital Expenditure: 8588000 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/873591/explain?concept=fundies%3ACapitalExpenditure&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 8588000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0001047469-03-007637.txt#5915 The citation records this snapshot. The page link may show a newer release later.	USD 164.68 million Calculation and evidence 173263000 − 8588000 USD Exact free cash flow: 164675000 USD 2000-01-01 – 2000-12-31: 173263000 USD · Inspect Operating Cash Flow · Source 2000-01-01 – 2000-12-31: 8588000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MEDIMMUNE INC /DE · 2000-12-31 MEDIMMUNE INC /DE (edgar:873591) Free cash flow: 164675000 USD Concept: free-cash-flow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/873591?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 173263000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0001047469-03-007637.txt#5819 Input fundies:CapitalExpenditure: 8588000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0001047469-03-007637.txt#5915 The citation records this snapshot. The page link may show a newer release later.
2001 2001-01-01 – 2001-12-31	USD 148.96 million Exact value Exact value: 148960000 USD 2001-01-01 – 2001-12-31: 148960000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MEDIMMUNE INC /DE · 2001-12-31 MEDIMMUNE INC /DE (edgar:873591) Net Income: 148960000 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/873591/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: 148960000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0001047469-04-007153.txt#5593 The citation records this snapshot. The page link may show a newer release later.	USD 250.92 million Exact value Exact value: 250915000 USD 2001-01-01 – 2001-12-31: 250915000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MEDIMMUNE INC /DE · 2001-12-31 MEDIMMUNE INC /DE (edgar:873591) Operating Cash Flow: 250915000 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/873591/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 250915000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0001047469-04-007153.txt#5931 The citation records this snapshot. The page link may show a newer release later.	USD 18.26 million Exact value Exact value: 18258000 USD 2001-01-01 – 2001-12-31: 18258000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MEDIMMUNE INC /DE · 2001-12-31 MEDIMMUNE INC /DE (edgar:873591) Capital Expenditure: 18258000 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/873591/explain?concept=fundies%3ACapitalExpenditure&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 18258000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0001047469-04-007153.txt#6025 The citation records this snapshot. The page link may show a newer release later.	USD 232.66 million Calculation and evidence 250915000 − 18258000 USD Exact free cash flow: 232657000 USD 2001-01-01 – 2001-12-31: 250915000 USD · Inspect Operating Cash Flow · Source 2001-01-01 – 2001-12-31: 18258000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MEDIMMUNE INC /DE · 2001-12-31 MEDIMMUNE INC /DE (edgar:873591) Free cash flow: 232657000 USD Concept: free-cash-flow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/873591?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 250915000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0001047469-04-007153.txt#5931 Input fundies:CapitalExpenditure: 18258000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0001047469-04-007153.txt#6025 The citation records this snapshot. The page link may show a newer release later.
2002 2002-01-01 – 2002-12-31	−USD 1.1 billion Exact value Exact value: -1098000000 USD 2002-01-01 – 2002-12-31: -1098000000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MEDIMMUNE INC /DE · 2002-12-31 MEDIMMUNE INC /DE (edgar:873591) Net Income: -1098000000 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/873591/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1098000000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0001104659-05-010003.txt#10788 The citation records this snapshot. The page link may show a newer release later.	USD 263.5 million Exact value Exact value: 263500000 USD 2002-01-01 – 2002-12-31: 263500000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MEDIMMUNE INC /DE · 2002-12-31 MEDIMMUNE INC /DE (edgar:873591) Operating Cash Flow: 263500000 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/873591/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 263500000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0001104659-05-010003.txt#11631 The citation records this snapshot. The page link may show a newer release later.	USD 80.9 million Exact value Exact value: 80900000 USD 2002-01-01 – 2002-12-31: 80900000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MEDIMMUNE INC /DE · 2002-12-31 MEDIMMUNE INC /DE (edgar:873591) Capital Expenditure: 80900000 USD Concept: fundies:CapitalExpenditure Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/873591/explain?concept=fundies%3ACapitalExpenditure&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 80900000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0001104659-05-010003.txt#11792 The citation records this snapshot. The page link may show a newer release later.	USD 182.6 million Calculation and evidence 263500000 − 80900000 USD Exact free cash flow: 182600000 USD 2002-01-01 – 2002-12-31: 263500000 USD · Inspect Operating Cash Flow · Source 2002-01-01 – 2002-12-31: 80900000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MEDIMMUNE INC /DE · 2002-12-31 MEDIMMUNE INC /DE (edgar:873591) Free cash flow: 182600000 USD Concept: free-cash-flow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/873591?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 263500000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0001104659-05-010003.txt#11631 Input fundies:CapitalExpenditure: 80900000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0001104659-05-010003.txt#11792 The citation records this snapshot. The page link may show a newer release later.
2003 2003-01-01 – 2003-12-31	USD 183.2 million Exact value Exact value: 183200000 USD 2003-01-01 – 2003-12-31: 183200000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MEDIMMUNE INC /DE · 2003-12-31 MEDIMMUNE INC /DE (edgar:873591) Net Income: 183200000 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/873591/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: 183200000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0000950133-06-001170.txt#8720 The citation records this snapshot. The page link may show a newer release later.	USD 357.5 million Exact value Exact value: 357500000 USD 2003-01-01 – 2003-12-31: 357500000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MEDIMMUNE INC /DE · 2003-12-31 MEDIMMUNE INC /DE (edgar:873591) Operating Cash Flow: 357500000 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/873591/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 357500000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0000950133-06-001170.txt#9063 The citation records this snapshot. The page link may show a newer release later.	USD 112.9 million Exact value Exact value: 112900000 USD 2003-01-01 – 2003-12-31: 112900000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MEDIMMUNE INC /DE · 2003-12-31 MEDIMMUNE INC /DE (edgar:873591) Capital Expenditure: 112900000 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/873591/explain?concept=fundies%3ACapitalExpenditure&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 112900000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0000950133-06-001170.txt#9171 The citation records this snapshot. The page link may show a newer release later.	USD 244.6 million Calculation and evidence 357500000 − 112900000 USD Exact free cash flow: 244600000 USD 2003-01-01 – 2003-12-31: 357500000 USD · Inspect Operating Cash Flow · Source 2003-01-01 – 2003-12-31: 112900000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MEDIMMUNE INC /DE · 2003-12-31 MEDIMMUNE INC /DE (edgar:873591) Free cash flow: 244600000 USD Concept: free-cash-flow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/873591?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 357500000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0000950133-06-001170.txt#9063 Input fundies:CapitalExpenditure: 112900000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0000950133-06-001170.txt#9171 The citation records this snapshot. The page link may show a newer release later.
2004 2004-01-01 – 2004-12-31	−USD 3.8 million Exact value Exact value: -3800000 USD 2004-01-01 – 2004-12-31: -3800000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MEDIMMUNE INC /DE · 2004-12-31 MEDIMMUNE INC /DE (edgar:873591) Net Income: -3800000 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/873591/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3800000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0001104659-07-014449.txt#11769 The citation records this snapshot. The page link may show a newer release later.	USD 144.7 million Exact value Exact value: 144700000 USD 2004-01-01 – 2004-12-31: 144700000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MEDIMMUNE INC /DE · 2004-12-31 MEDIMMUNE INC /DE (edgar:873591) Operating Cash Flow: 144700000 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/873591/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 144700000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0001104659-07-014449.txt#12393 The citation records this snapshot. The page link may show a newer release later.	USD 79.8 million Exact value Exact value: 79800000 USD 2004-01-01 – 2004-12-31: 79800000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MEDIMMUNE INC /DE · 2004-12-31 MEDIMMUNE INC /DE (edgar:873591) Capital Expenditure: 79800000 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/873591/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 79800000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0001104659-07-014449.txt#12527 The citation records this snapshot. The page link may show a newer release later.	USD 64.9 million Calculation and evidence 144700000 − 79800000 USD Exact free cash flow: 64900000 USD 2004-01-01 – 2004-12-31: 144700000 USD · Inspect Operating Cash Flow · Source 2004-01-01 – 2004-12-31: 79800000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MEDIMMUNE INC /DE · 2004-12-31 MEDIMMUNE INC /DE (edgar:873591) Free cash flow: 64900000 USD Concept: free-cash-flow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/873591?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 144700000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0001104659-07-014449.txt#12393 Input fundies:CapitalExpenditure: 79800000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0001104659-07-014449.txt#12527 The citation records this snapshot. The page link may show a newer release later.
2005 2005-01-01 – 2005-12-31	−USD 16.6 million Exact value Exact value: -16600000 USD 2005-01-01 – 2005-12-31: -16600000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MEDIMMUNE INC /DE · 2005-12-31 MEDIMMUNE INC /DE (edgar:873591) Net Income: -16600000 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/873591/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -16600000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0001104659-07-014449.txt#11769 The citation records this snapshot. The page link may show a newer release later.	USD 110.7 million Exact value Exact value: 110700000 USD 2005-01-01 – 2005-12-31: 110700000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MEDIMMUNE INC /DE · 2005-12-31 MEDIMMUNE INC /DE (edgar:873591) Operating Cash Flow: 110700000 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/873591/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 110700000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0001104659-07-014449.txt#12393 The citation records this snapshot. The page link may show a newer release later.	USD 91.5 million Exact value Exact value: 91500000 USD 2005-01-01 – 2005-12-31: 91500000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MEDIMMUNE INC /DE · 2005-12-31 MEDIMMUNE INC /DE (edgar:873591) Capital Expenditure: 91500000 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/873591/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 91500000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0001104659-07-014449.txt#12527 The citation records this snapshot. The page link may show a newer release later.	USD 19.2 million Calculation and evidence 110700000 − 91500000 USD Exact free cash flow: 19200000 USD 2005-01-01 – 2005-12-31: 110700000 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 91500000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MEDIMMUNE INC /DE · 2005-12-31 MEDIMMUNE INC /DE (edgar:873591) Free cash flow: 19200000 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/873591?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 110700000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0001104659-07-014449.txt#12393 Input fundies:CapitalExpenditure: 91500000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0001104659-07-014449.txt#12527 The citation records this snapshot. The page link may show a newer release later.
2006 2006-01-01 – 2006-12-31	USD 48.7 million Exact value Exact value: 48700000 USD 2006-01-01 – 2006-12-31: 48700000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MEDIMMUNE INC /DE · 2006-12-31 MEDIMMUNE INC /DE (edgar:873591) Net Income: 48700000 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/873591/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: 48700000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0001104659-07-014449.txt#11769 The citation records this snapshot. The page link may show a newer release later.	−USD 127.6 million Exact value Exact value: -127600000 USD 2006-01-01 – 2006-12-31: -127600000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MEDIMMUNE INC /DE · 2006-12-31 MEDIMMUNE INC /DE (edgar:873591) Operating Cash Flow: -127600000 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/873591/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -127600000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0001104659-07-014449.txt#12393 The citation records this snapshot. The page link may show a newer release later.	USD 142.2 million Exact value Exact value: 142200000 USD 2006-01-01 – 2006-12-31: 142200000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MEDIMMUNE INC /DE · 2006-12-31 MEDIMMUNE INC /DE (edgar:873591) Capital Expenditure: 142200000 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/873591/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 142200000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0001104659-07-014449.txt#12527 The citation records this snapshot. The page link may show a newer release later.	−USD 269.8 million Calculation and evidence -127600000 − 142200000 USD Exact free cash flow: -269800000 USD 2006-01-01 – 2006-12-31: -127600000 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 142200000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MEDIMMUNE INC /DE · 2006-12-31 MEDIMMUNE INC /DE (edgar:873591) Free cash flow: -269800000 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/873591?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -127600000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0001104659-07-014449.txt#12393 Input fundies:CapitalExpenditure: 142200000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/873591/0001104659-07-014449.txt#12527 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

59 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000873591, 873591, edgar:873591

MEDIMMUNE INC /DE

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2006 2006-01-01 – 2006-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation